Velarion · Company Intelligence
Compensation Brief
Fiscal year 2022 · Filings through 2026-06-08

Seagen (SGEN)

CEO David Epstein was paid $57,460,546 in fiscal year 2022, the 99th percentile of its disclosed peer group (SEC filing 0001060736-23-000019 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$57,460,546
David Epstein total, FY2022
99th
CEO pay percentile vs peers
—
CEO-to-median pay ratio
54.38%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

01

Summary Compensation Table — fiscal year 2022

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
David Epstein$190,385$0$14,815,386$42,381,246$0$0$73,529$57,460,546
Chief Executive Officer
Roger Dansey1,030,497015,224,56918,684,6001,432,116018,97136,390,753
President, Research and Development and Chief Medical Officer
Clay Siegall463,339021,170,1066,972,570004,152,00732,758,022
Former President and Chief Executive Officer
Jean Liu678,75004,723,2350532,350018,9715,953,306
Chief Legal Officer
Todd Simpson672,42504,446,5430569,354018,9715,707,293
Chief Financial Officer
Chip Romp626,53903,952,5700448,87502,6815,030,665
Executive Vice President, Commercial U.S.
Vaughn Himes589,36203,458,4290469,607018,9714,536,369
Chief Technical Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2022 totalFY2021 totalFY2020 totalΔ FY2021→2022
David Epstein$57,460,546———
Roger Dansey36,390,7538,861,1407,061,537↑ +27,529,613
Clay Siegall32,758,02218,906,44416,493,557↑ +13,851,578
Jean Liu5,953,3065,123,2073,913,724↑ +830,099
Todd Simpson5,707,2935,986,9404,601,531↓ −279,647
Chip Romp5,030,6655,288,7084,577,582↓ −258,043
Vaughn Himes4,536,3694,911,8763,678,473↓ −375,507

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Seagen's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper SGEN reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against SGEN
1 company names SGEN as a compensation peer

The list of companies that name SGEN as a peer is temporarily unavailable — recheck shortly.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2022 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Vaughn HimesChief Technical Officer2023-12-14D8,333——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D20,626——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D642——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D15,719——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D636——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D41,453——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D1,333——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D41,343——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D1,301——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D47,844——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D40,293——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D34,946——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D17,662——Derivative, Class A CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D119,47122927,358,859CommonForm 4 ↗
Vaughn HimesChief Technical Officer2023-12-14D14,8742293,406,146CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D5,149——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D8,582——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D3,432——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D1,827——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D13,279——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D4,980——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D2,575——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D4,291——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D41,174——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D16,547——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D10,184——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D1,717——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D11,900——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D4,756——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D25,747——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D2,260——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D33,468——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D8,586——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D3,298——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D154,000——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D41,250——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D642——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D32,073——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D636——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D18,083——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D1,333——Derivative, Class A CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D6,140——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D2,044——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D3,676——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D3,462——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D3,171——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D7,038——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D13,217——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D5,286——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D3,965——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D6,608——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D2,644——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D39,650——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D80,541——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D224,000——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D240,451——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D2,896——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D4,622——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D1,798——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D21,915——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D642——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D17,205——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D636——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D43,786——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D1,333——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D40,523——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D16,4072293,757,203CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D40,344——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D35,293——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D7,446——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D48,74822911,163,292CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D1,747——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D2,912——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D1,165——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D1,305——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D874——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D1,457——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D12,688——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D9,423——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D5,554——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D583——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D3,662——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D2,708——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D13,107——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D1,389——Derivative, Class A CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D10,298——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D1,966——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D3,276——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D1,310——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D1,827——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D983——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D1,639——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D14,251——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D11,400——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D6,666——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D656——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D4,120——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D3,276——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D14,746——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D5,547——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D2,158——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D10,526——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D26,427——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D642——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D20,774——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D636——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D49,232——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D1,333——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D47,904——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D1,301——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D93,29222921,363,868CommonForm 4 ↗
Roger DanseyPresident, R&D & CMO2023-12-14D38,3382298,779,402CommonForm 4 ↗
Jean LiuChief Legal Officer2023-12-14D4,436——Derivative, Class A CommonForm 4 ↗
John A. OrwinDirector2023-12-14D12,500——Derivative, Class A CommonForm 4 ↗
John A. OrwinDirector2023-12-14D29,0032296,641,687CommonForm 4 ↗
David W. GryskaDirector2023-12-14D8,750——Derivative, Class A CommonForm 4 ↗
David W. GryskaDirector2023-12-14D49,00322911,221,687CommonForm 4 ↗
Daniel G. WelchDirector2023-12-14D4,7502291,087,750CommonForm 4 ↗
Sandra M. SwainDirector2023-12-14D2,044——Derivative, Class A CommonForm 4 ↗
Sandra M. SwainDirector2023-12-14D1,763——Derivative, Class A CommonForm 4 ↗
Sandra M. SwainDirector2023-12-14D778229178,162CommonForm 4 ↗
Ted W. LoveDirector2023-12-14D2,044——Derivative, Class A CommonForm 4 ↗
Ted W. LoveDirector2023-12-14D449——Derivative, Class A CommonForm 4 ↗
Ted W. LoveDirector2023-12-14D3,676——Derivative, Class A CommonForm 4 ↗
Ted W. LoveDirector2023-12-14D3,462——Derivative, Class A CommonForm 4 ↗
Ted W. LoveDirector2023-12-14D4,460——Derivative, Class A CommonForm 4 ↗
Ted W. LoveDirector2023-12-14D4,255229974,395CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D1,395——Derivative, Class A CommonForm 4 ↗
Todd SimpsonChief Financial Officer2023-12-14D11,585——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D3,676——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D3,462——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D3,371——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D7,038——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D8,750——Derivative, Class A CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D42,977,3012299,841,801,929CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D1,731,202229396,445,258CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D23,2772295,330,433CommonForm 4 ↗
BAKER BROS. ADVISORS LPDirector2023-12-14D23,2802295,331,120CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D2,912——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D1,165——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D1,044——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D874——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D1,457——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D12,688——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D9,883——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D6,017——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D583——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D3,662——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D2,840——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D13,107——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D1,294——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D10,298——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D4,953——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D1,948——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D861——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D2,854——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D3,179——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D642——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D23,526——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D617——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D18,711——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D11,849——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D1,376——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D12,476——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D1,301——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D19,719——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D2,156——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D17,374——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D33,7962297,739,284CommonForm 4 ↗
John A. OrwinDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
David R. EpsteinDirector2023-12-14D7,930——Derivative, Class A CommonForm 4 ↗
Chip RompEVP, Commercial U.S.2023-12-14D1,747——Derivative, Class A CommonForm 4 ↗
Alpna SethDirector2023-12-14D2,044——Derivative, Class A CommonForm 4 ↗
Alpna SethDirector2023-12-14D3,676——Derivative, Class A CommonForm 4 ↗
Alpna SethDirector2023-12-14D3,462——Derivative, Class A CommonForm 4 ↗
Alpna SethDirector2023-12-14D3,171——Derivative, Class A CommonForm 4 ↗
Alpna SethDirector2023-12-14D7,038——Derivative, Class A CommonForm 4 ↗
Alpna SethDirector2023-12-14D14,250——Derivative, Class A CommonForm 4 ↗
Alpna SethDirector2023-12-14D12,9532292,966,237CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D2,044——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D3,676——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D3,462——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D3,171——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D7,038——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D9,260——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D8,750——Derivative, Class A CommonForm 4 ↗
Nancy A. SimonianDirector2023-12-14D62,75322914,370,437CommonForm 4 ↗
Daniel G. WelchDirector2023-12-14D2,044——Derivative, Class A CommonForm 4 ↗
Daniel G. WelchDirector2023-12-14D10,7252292,456,025CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2022

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Clay SiegallRSU2022-05-15——13,991—$1,897,599
Clay SiegallRSU2022-05-15——15,411—2,090,194
Roger DanseyPSU2022-01-181,66018,259—18,2592,378,965
Vaughn HimesPSU2022-08-154011,602—3,204353,770
Clay SiegallPSU2022-05-152,0018,006—16,0121,887,317
Clay SiegallPSU2022-05-1516,01132,023—64,0468,686,424
Todd SimpsonPSU2022-08-155152,060—4,120454,910
Roger DanseyOPTION2022-11-0955,000275,000—275,00018,684,600
Clay SiegallRSU2022-05-15——23,995—3,254,442
Jean LiuRSU2022-01-18——5,915—770,665
Jean LiuRSU2022-08-15——13,731—2,314,085
Chip RompPSU2022-08-153,6627,323—14,6461,234,145
Clay SiegallOPTION2022-05-15——137,500—119,625
Clay SiegallOPTION2022-05-15——150,000—142,500
Clay SiegallOPTION2022-05-15——168,000—171,360
Clay SiegallOPTION2022-05-15——114,095—2,748,950
Todd SimpsonRSU2022-08-15——15,447—2,603,283
Clay SiegallRSU2022-05-15——24,016—3,257,290
Jean LiuPSU2022-08-153,6627,323—14,6461,234,145
Todd SimpsonPSU2022-08-154,1198,238—16,4761,388,350
Vaughn HimesPSU2022-08-153,2046,408—12,8161,079,940
Roger DanseyPSU2022-08-1511,90023,800—47,6004,011,014
Jean LiuPSU2022-08-154581,831—3,662404,340
Clay SiegallRSU2022-05-15——714—96,840
Roger DanseyPSU2022-08-151,4885,950—11,9001,313,939
David EpsteinRSU2022-11-09——107,389—14,815,386
Vaughn HimesRSU2022-08-15——12,014—2,024,719
Chip RompPSU2022-08-154581,831—3,662404,340
Chip RompRSU2022-08-15——13,731—2,314,085
Roger DanseyRSU2022-08-15——44,625—7,520,651
Clay SiegallOPTION2022-05-15——180,000—176,400
Clay SiegallOPTION2022-05-15——54,928—797,326
Clay SiegallOPTION2022-05-15——37,280—26,842
David EpsteinOPTION2022-11-0980,000400,000—400,00027,177,600
David EpsteinOPTION2022-11-09——243,347—15,203,646
Clay SiegallOPTION2022-05-15——160,000—132,800
Clay SiegallOPTION2022-05-15——227,984—1,855,240
Clay SiegallOPTION2022-05-15——40,728—801,527
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Clay Siegall$10,596,365$10,573,741$6,972,57037.6%
Roger Dansey7,520,6517,703,91818,684,60022.7%
Vaughn Himes2,024,7191,433,710041.5%
Todd Simpson2,603,2831,843,260041.5%
Jean Liu3,084,7501,638,485034.7%
Chip Romp2,314,0851,638,485041.5%
David Epstein14,815,386042,381,2460.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2022

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Chip RompPSU1,420—$182,484
Clay SiegallPSU8,440—1,084,624
Chip RompRSU7,430—954,829
Vaughn HimesRSU6,538—840,198
Roger DanseyPSU5,277—678,147
Chip RompPSU3,118—400,694
Jean LiuPSU1,740—223,607
Chip RompPSU780—100,238
Clay SiegallRSU714—91,756
Roger DanseyOption11,66972.64—
Clay SiegallOption38,03272.64—
Chip RompOption2,20472.64—
Chip RompOption8,054161.82—
Chip RompOption16,112155.87—
Vaughn HimesOption7,13172.64—
Vaughn HimesOption6,815161.82—
Vaughn HimesOption14,179155.87—
Jean LiuPSU7,323—941,079
David EpsteinRSU243,347—31,272,522
David EpsteinRSU107,389—13,800,560
Vaughn HimesPSU675,000—86,744,242
Clay SiegallRSU121,881—15,662,927
Clay SiegallPSU100,532—12,919,367
Clay SiegallRSU28,909—3,715,095
Roger DanseyPSU23,800—3,058,538
Clay SiegallRSU20,986—2,696,911
Jean LiuRSU13,731—1,764,571
Clay SiegallPSU9,607—1,234,596
Roger DanseyPSU9,510—1,222,130
Clay SiegallPSU7,485—961,897
Roger DanseyRSU7,368—946,862
Jean LiuRSU6,934—891,088
Chip RompPSU5,680—729,937
Jean LiuRSU5,915—760,137
Vaughn HimesPSU5,601—719,785
Clay SiegallPSU5,596—719,142
Jean LiuPSU5,416—696,010
Todd SimpsonRSU5,322—683,930
Jean LiuRSU3,597—462,250
Jean LiuPSU1,831—235,302
Jean LiuPSU2,878—369,852
Chip RompRSU1,798—231,061
Chip RompRSU1,392—178,886
Vaughn HimesPSU1,602—205,873
Jean LiuPSU720—92,527
Jean LiuRSU160—20,562
Roger DanseyRSU129—16,578
Clay SiegallOption18,99976.86—
Clay SiegallOption75,191155.87—
Todd SimpsonOption8,42872.64—
Todd SimpsonOption18,046155.87—
Jean LiuOption7,434161.82—
Chip RompRSU13,731—1,764,571
David EpsteinPSU107,389—13,800,560
Chip RompPSU1,831—235,302
Chip RompPSU7,323—941,079
Roger DanseyOption13,629161.82—
Todd SimpsonRSU4,317—554,778
Vaughn HimesPSU1,400—179,914
Roger DanseyRSU12,879—1,655,080
Chip RompRSU3,897—500,803
Roger DanseyRSU1,442—185,311
Clay SiegallRSU24,016—3,086,296
Todd SimpsonPSU1,638—210,499
Todd SimpsonRSU201—25,831
Vaughn HimesRSU201—25,831
Roger DanseyPSU2,378—305,597
Chip RompRSU112—14,393
Todd SimpsonPSU2,060—264,731
Chip RompPSU1,392—178,886
Roger DanseyPSU1,319—169,505
Roger DanseyPSU275,000—35,340,249
Todd SimpsonRSU25,241—3,243,721
Vaughn HimesRSU20,745—2,665,940
Clay SiegallRSU23,995—3,083,597
Vaughn HimesPSU6,408—823,492
Vaughn HimesPSU2,436—313,050
Jean LiuRSU4,748—610,165
Todd SimpsonPSU8,238—1,058,665
Roger DanseyOption27,928155.87—
05

Incentive-plan design — the Compensation Discussion & Analysis

Our compensation philosophy is to provide overall compensation that is competitive with biotechnology peers to attract and retain the highest caliber executive talent. Key objectives of our executive compensation program include: Supporting our business strategy; Aligning pay with company performance and executive officer performance with shareholder interests; Attracting, retaining and motivating our executive officers and maintaining competitiveness with companies we compete with for talent; Rewarding success in building both short- and long-term growth; Weighting pay deliberately toward "at risk" performance-based compensation; Ensuring that our pay practices are executed consistently and fairly for all executives, regardless of ethnicity or gender; Motivating performance that aligns with our corporate values of integrity, scientific excellence, teamwork, innovation and mutual respect.

CEO STI target (% of salary)150%
CEO LTI target (% of salary)—
Independent consultantAon
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20232023-05-3190,103,44375,602,290151,48654.38%Passed
20222022-05-19140,889,62324,997,81572,79584.93%Passed
20212021-05-19138,283,30823,289,86185,00585.59%Passed
20202020-05-19149,358,3027,864,729193,80295%Passed
20192019-05-23106,830,45639,391,697132,21573.06%Passed
20182018-05-18138,922,6931,894,754105,44898.65%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20232023-05-3154.38%a
20222022-05-1984.93%b
20212021-05-1985.59%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

08

Director compensation — fiscal year 2022

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Felix J. Baker, Ph.DIndependent · Board Chair · Compensation (Chair) · Governance$130,000$203,852$194,675—$0$528,527
David W. GryskaIndependent · Audit (Chair)85,000203,852194,675—0483,527
Nancy A. Simonian, M.DIndependent · Governance (Chair)76,000203,852194,675—0474,527
Ted W. Love, M.DIndependent · Audit72,500203,852194,675—0471,027
Alpna H. Seth, Ph.DIndependent · Audit72,500203,852194,675—0471,027
Daniel G. WelchIndependent · Compensation70,000203,852194,675—0468,527
John A. OrwinIndependent · Compensation70,000203,852194,675—0468,527
Sandra M. Swain, M.DIndependent · Governance · Newly elected8,641107,33398,757—0214,731
Marc E. Lippman, M.DIndependent · Governance · Not standing for re-election · Departed during FY25,033———025,033
David R. EpsteinEmployee director · Newly elected000—00
09

Board fee structure and ownership guideline

Annual cash retainer$60,000
Annual equity retainer$400,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)12,500 / 22,000 / 16,000
Stock ownership guideline5x annual cash retainer for Board service (not including committee retainers)
09b

Total cost of the board

ComponentFY2022
Cash retainers and fees$609,674
Equity awards (grant-date value)$1,534,297
All other compensation$0
Total cost of the board$2,143,971

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2022

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Seagen names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Seagen.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Seagen2022David Epstein$190,385$14,815,386$42,381,246$0$57,460,546
2Exelixis, Inc.2025Michael Morrissey1,306,04030,539,55201,382,59133,239,183
3Incyte Corporation2025William Meury647,26027,509,6572,573,9981,300,00032,085,952
4Biogen Inc.2025Christopher Viehbacher1,727,88518,368,87503,190,87523,646,004
5BioMarin Pharmaceutical Inc.2025Alexander Hardy1,130,76916,833,6291,909,3101,644,50021,927,563
6Vertex Pharmaceuticals Incorporated2025Reshma Kewalramani1,600,00015,002,27004,118,64021,144,261
7Horizon Therapeutics plc2022Timothy Walbert1,292,72716,601,3050020,103,869
8Moderna, Inc.2025Stéphane Bancel1,677,7396,897,4556,897,4254,302,36019,932,217
9Jazz Pharmaceuticals plc2025Renee Gala1,003,26916,138,43301,980,00019,151,558
10United Therapeutics Corporation2025Martine Rothblatt1,545,0056,067,9906,075,8044,281,87518,038,972
11Exact Sciences Corporation2024Kevin Conroy1,083,36813,496,1380712,32915,539,378
12Alnylam Pharmaceuticals, Inc.2025Yvonne Greenstreet1,404,2005,512,5004,363,3803,562,50014,867,600
13Neurocrine Biosciences, Inc.2025Kyle Gano920,0005,750,0235,750,006013,448,935
14Regeneron Pharmaceuticals, Inc.2025Leonard Schleifer1,979,922——3,682,6557,280,549

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Seagen130%RSU 60 · PSU 40Yes — Relative TSRAon
Alnylam Pharmaceuticals, Inc.200%PSU 50 · RSU 25 · Option 25NoPay Governance
Biogen Inc.127%PSU 60 · RSU 40YesPay Governance
BioMarin Pharmaceutical Inc.130%PSU 66 · RSU 21 · Options 13Yes — Relative TSRAon Human Capital Solutions
Exact Sciences Corporation47%PSU 60 · RSU 40NoAon
Exelixis, Inc.105%PSU 50 · RSU 50Yes — 2025 Relative TSR GoalAon
Horizon Therapeutics plc100%RSU 50 · PSU 50Yes — Relative TSRAon
Incyte Corporation138.6%Performance Shares 60 · RSU 40Yes — relative total shareholder return (TSR)Aon
Jazz Pharmaceuticals plc150%PSU 50 · RSU 50Yes — Relative TSRAon
Moderna, Inc.170%PSU 50 · Options 50NoPay Governance LLC
Neurocrine Biosciences, Inc.105%Options 50 · PSU 30 · RSU 20NoFrederic W. Cook & Co., Inc.
Regeneron Pharmaceuticals, Inc.155%Options 60 · RSU 40not disclosedPay Governance LLC
United Therapeutics Corporation221%PSO 50 · PSU 50NoAon
Vertex Pharmaceuticals Incorporatednot disclosedPSU 55 · RSU 45NoPearl Meyer

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at Seagen in fiscal 2022?
As disclosed, David Epstein (Chief Executive Officer) was the highest-paid executive at Seagen in fiscal 2022, with total compensation of $57,460,546.
How does Seagen's chief executive pay compare to its disclosed peer group?
As disclosed, David Epstein's total compensation ranked at the 99th percentile of Seagen's disclosed peer group.
How did shareholders vote on Seagen's executive compensation?
As disclosed, 54.38% of shareholders supported Seagen's executive compensation in the latest say-on-pay vote.
How much does Seagen spend in total on board compensation for fiscal 2022?
As disclosed, Seagen reported total board compensation of $2,143,971 for fiscal 2022.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, David EpsteinDEF 14A2023-04-180001060736-23-000019Section “Summary Compensation Table” · page 87. As printed: 57,460,546. Filing ↗machine: r2 · c36 · span 1339226–1339236
2Section 01, Roger DanseyDEF 14A2023-04-180001060736-23-000019Section “Summary Compensation Table” · page 87. As printed: 36,390,753. Filing ↗machine: r4 · c36 · span 1342351–1342361
3Section 01, Clay SiegallDEF 14A2023-04-180001060736-23-000019Section “Summary Compensation Table” · page 87. As printed: 32,758,022. Filing ↗machine: t212 · r7 · c13 · span 1351680–1351690
4Section 01, Jean LiuDEF 14A2023-04-180001060736-23-000019Section “Summary Compensation Table” · page 87. As printed: 5,953,306. Filing ↗machine: r13 · c36 · span 1368323–1368332
5Section 01, Todd SimpsonDEF 14A2023-04-180001060736-23-000019Section “Summary Compensation Table” · page 87. As printed: 5,707,293. Filing ↗machine: r10 · c36 · span 1359970–1359979
6Section 01, Chip RompDEF 14A2023-04-180001060736-23-000019Section “Summary Compensation Table” · page 87. As printed: 5,030,665. Filing ↗machine: r16 · c36 · span 1376619–1376628
7Section 01, Vaughn HimesDEF 14A2023-04-180001060736-23-000019Section “Summary Compensation Table” · page 87. As printed: 4,536,369. Filing ↗machine: r19 · c36 · span 1385092–1385101
8Section 03, Clay Siegall RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
9Section 03, Clay Siegall RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
10Section 03, Roger Dansey PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r25 · c11 · span 1697296–1697302
11Section 03, Vaughn Himes PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t230 · r26 · c11 · span 2014440–2014445
12Section 03, Clay Siegall PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
13Section 03, Clay Siegall PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
14Section 03, Todd Simpson PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t226 · r24 · c11 · span 1814431–1814436
15Section 03, Roger Dansey OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r14 · c5 · span 1672315–1672322
16Section 03, Clay Siegall RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r35 · c8 · span 1720674–1720680
17Section 03, Jean Liu RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t228 · r21 · c8 · span 1875345–1875350
18Section 03, Jean Liu RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t228 · r22 · c8 · span 1877562–1877568
19Section 03, Chip Romp PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t228 · r47 · c11 · span 1937105–1937110
20Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
21Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
22Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
23Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
24Section 03, Todd Simpson RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t226 · r22 · c8 · span 1809453–1809459
25Section 03, Clay Siegall RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r36 · c8 · span 1723346–1723352
26Section 03, Jean Liu PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t228 · r23 · c11 · span 1880371–1880376
27Section 03, Todd Simpson PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t226 · r23 · c11 · span 1812237–1812242
28Section 03, Vaughn Himes PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t230 · r25 · c11 · span 2012223–2012228
29Section 03, Roger Dansey PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r27 · c11 · span 1701763–1701769
30Section 03, Jean Liu PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t228 · r24 · c11 · span 1882588–1882593
31Section 03, Clay Siegall RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r46 · c8 · span 1745747–1745750
32Section 03, Roger Dansey PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r28 · c11 · span 1703983–1703988
33Section 03, David Epstein RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r7 · c8 · span 1654977–1654984
34Section 03, Vaughn Himes RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t230 · r24 · c8 · span 2009290–2009296
35Section 03, Chip Romp PSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t228 · r48 · c11 · span 1939745–1939750
36Section 03, Chip Romp RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t228 · r46 · c8 · span 1934251–1934257
37Section 03, Roger Dansey RSUDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r26 · c8 · span 1698954–1698960
38Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
39Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
40Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
41Section 03, David Epstein OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r6 · c5 · span 1652403–1652410
42Section 03, David Epstein OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗machine: t224 · r5 · c3 · span 1649643–1649650
43Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
44Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
45Section 03, Clay Siegall OPTIONDEF 14A2023-04-180001060736-23-000019Section “Grants of Plan-Based Awards in 202” · grants of plan-based awards table. Filing ↗
46Section 08, Felix J. Baker, Ph.DDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 528,527. Filing ↗machine: t107 · r2 · c8 · span 757909–758048
47Section 08, David W. GryskaDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 483,527. Filing ↗machine: t107 · r3 · c7 · span 759722–759861
48Section 08, Nancy A. Simonian, M.DDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 474,527. Filing ↗machine: t107 · r7 · c8 · span 767107–767246
49Section 08, Ted W. Love, M.DDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 471,027. Filing ↗machine: t107 · r4 · c7 · span 761536–761675
50Section 08, Alpna H. Seth, Ph.DDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 471,027. Filing ↗machine: t107 · r6 · c7 · span 765165–765304
51Section 08, Daniel G. WelchDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 468,527. Filing ↗machine: t107 · r9 · c7 · span 770846–770985
52Section 08, John A. OrwinDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 468,527. Filing ↗machine: t107 · r5 · c7 · span 763347–763486
53Section 08, Sandra M. Swain, M.DDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 214,731. Filing ↗machine: t107 · r8 · c8 · span 769032–769171
54Section 08, Marc E. Lippman, M.DDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 25,033. Filing ↗machine: t107 · r10 · c1 · span 771734–771902
55Section 08, David R. EpsteinDEF 14A2023-04-180001060736-23-000019Section “Director Compensation”. As printed: 0. Filing ↗
56Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Vaughn Himes 2023-12-14Form 42023-12-150000950170-23-070886Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
105Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
106Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
107Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
108Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
109Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
110Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
111Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
112Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
113Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
114Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
115Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
116Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
117Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
118Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
119Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
120Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
121Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
122Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
123Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
124Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
125Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
126Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
127Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
128Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
129Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
130Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
131Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
132Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
133Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
134Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
135Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
136Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
137Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
138Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
139Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
140Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
141Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
142Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
143Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
144Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
145Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
146Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
147Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
148Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
149Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
150Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
151Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
152Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
153Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
154Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
155Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
156Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
157Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
158Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
159Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
160Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
161Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
162Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
163Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
164Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
165Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
166Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
167Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
168Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
169Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
170Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
171Section 02, Roger Dansey 2023-12-14Form 42023-12-150000950170-23-070861Insider equity transaction reported since the proxy statement. Filing ↗
172Section 02, Jean Liu 2023-12-14Form 42023-12-150000950170-23-070875Insider equity transaction reported since the proxy statement. Filing ↗
173Section 02, John A. Orwin 2023-12-14Form 42023-12-150000950170-23-070863Insider equity transaction reported since the proxy statement. Filing ↗
174Section 02, John A. Orwin 2023-12-14Form 42023-12-150000950170-23-070863Insider equity transaction reported since the proxy statement. Filing ↗
175Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
176Section 02, David W. Gryska 2023-12-14Form 42023-12-150000950170-23-070865Insider equity transaction reported since the proxy statement. Filing ↗
177Section 02, Daniel G. Welch 2023-12-14Form 42023-12-150000950170-23-070874Insider equity transaction reported since the proxy statement. Filing ↗
178Section 02, Sandra M. Swain 2023-12-14Form 42023-12-150000950170-23-070879Insider equity transaction reported since the proxy statement. Filing ↗
179Section 02, Sandra M. Swain 2023-12-14Form 42023-12-150000950170-23-070879Insider equity transaction reported since the proxy statement. Filing ↗
180Section 02, Sandra M. Swain 2023-12-14Form 42023-12-150000950170-23-070879Insider equity transaction reported since the proxy statement. Filing ↗
181Section 02, Ted W. Love 2023-12-14Form 42023-12-150000950170-23-070880Insider equity transaction reported since the proxy statement. Filing ↗
182Section 02, Ted W. Love 2023-12-14Form 42023-12-150000950170-23-070880Insider equity transaction reported since the proxy statement. Filing ↗
183Section 02, Ted W. Love 2023-12-14Form 42023-12-150000950170-23-070880Insider equity transaction reported since the proxy statement. Filing ↗
184Section 02, Ted W. Love 2023-12-14Form 42023-12-150000950170-23-070880Insider equity transaction reported since the proxy statement. Filing ↗
185Section 02, Ted W. Love 2023-12-14Form 42023-12-150000950170-23-070880Insider equity transaction reported since the proxy statement. Filing ↗
186Section 02, Ted W. Love 2023-12-14Form 42023-12-150000950170-23-070880Insider equity transaction reported since the proxy statement. Filing ↗
187Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
188Section 02, Todd Simpson 2023-12-14Form 42023-12-150000950170-23-070882Insider equity transaction reported since the proxy statement. Filing ↗
189Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
190Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
191Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
192Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
193Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
194Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
195Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
196Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
197Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
198Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
199Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
200Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
201Section 02, BAKER BROS. ADVISORS LP 2023-12-14Form 42023-12-180001209191-23-059034Insider equity transaction reported since the proxy statement. Filing ↗
202Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
203Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
204Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
205Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
206Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
207Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
208Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
209Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
210Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
211Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
212Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
213Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
214Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
215Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
216Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
217Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
218Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
219Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
220Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
221Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
222Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
223Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
224Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
225Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
226Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
227Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
228Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
229Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
230Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
231Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
232Section 02, Chip Romp 2023-12-14Form 42023-12-150000950170-23-070857Insider equity transaction reported since the proxy statement. Filing ↗
233Section 02, John A. Orwin 2023-12-14Form 42023-12-150000950170-23-070863Insider equity transaction reported since the proxy statement. Filing ↗
234Section 02, David R. Epstein 2023-12-14Form 42023-12-150000950170-23-070873Insider equity transaction reported since the proxy statement. Filing ↗
235Section 02, Chip Romp 2023-12-14Form 42023-12-150000899243-23-020646Insider equity transaction reported since the proxy statement. Filing ↗
236Section 02, Alpna Seth 2023-12-14Form 42023-12-150000950170-23-070868Insider equity transaction reported since the proxy statement. Filing ↗
237Section 02, Alpna Seth 2023-12-14Form 42023-12-150000950170-23-070868Insider equity transaction reported since the proxy statement. Filing ↗
238Section 02, Alpna Seth 2023-12-14Form 42023-12-150000950170-23-070868Insider equity transaction reported since the proxy statement. Filing ↗
239Section 02, Alpna Seth 2023-12-14Form 42023-12-150000950170-23-070868Insider equity transaction reported since the proxy statement. Filing ↗
240Section 02, Alpna Seth 2023-12-14Form 42023-12-150000950170-23-070868Insider equity transaction reported since the proxy statement. Filing ↗
241Section 02, Alpna Seth 2023-12-14Form 42023-12-150000950170-23-070868Insider equity transaction reported since the proxy statement. Filing ↗
242Section 02, Alpna Seth 2023-12-14Form 42023-12-150000950170-23-070868Insider equity transaction reported since the proxy statement. Filing ↗
243Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
244Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
245Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
246Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
247Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
248Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
249Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
250Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
251Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
252Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
253Section 02, Nancy A. Simonian 2023-12-14Form 42023-12-150000950170-23-070884Insider equity transaction reported since the proxy statement. Filing ↗
254Section 02, Daniel G. Welch 2023-12-14Form 42023-12-150000950170-23-070874Insider equity transaction reported since the proxy statement. Filing ↗
255Section 02, Daniel G. Welch 2023-12-14Form 42023-12-150000950170-23-070874Insider equity transaction reported since the proxy statement. Filing ↗
256Section 06, 2023 voteForm 8-K2023-06-010001193125-23-158445Item 5.07 · say-on-pay result. As reported: 54.38% (votes for as printed: 90,103,443). Filing ↗
257Section 06, 2022 voteForm 8-K2022-05-190001193125-22-155105Item 5.07 · say-on-pay result. As reported: 84.93% (votes for as printed: 140,889,623). Filing ↗
258Section 06, 2021 voteForm 8-K2021-05-190001193125-21-166689Item 5.07 · say-on-pay result. As reported: 85.59%. Filing ↗
259Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
260Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
261Section 09b board cost (computed)Computed——Cash 609,674 + equity 1,534,297 + all other 0 = 2,143,971, summed across the director compensation table rows.machine: formula: Σ = 2,143,971
262Seagen (subject), Section 10b CEO totalDEF 14A2023-04-180001060736-23-000019CEO total compensation as printed in Seagen's own proxy. As printed: 57,460,546. Filing ↗machine: r2 · c36 · span 1339226–1339236
263Exelixis, Inc., Section 10b CEO totalDEF 14A2026-04-150000939767-26-000046CEO total compensation as printed in Exelixis, Inc.'s own proxy. As printed: 33,239,183. Filing ↗machine: r2 · c10 · span 2655516–2655526
264Incyte Corporation, Section 10b CEO totalDEF 14A2026-04-280000879169-26-000031CEO total compensation as printed in Incyte Corporation's own proxy. As printed: 32,085,952. Filing ↗machine: t91 · r2 · c16 · span 637817–637827
265Biogen Inc., Section 10b CEO totalDEF 14A2026-04-280001193125-26-187303CEO total compensation as printed in Biogen Inc.'s own proxy. As printed: 23,646,004. Filing ↗machine: r2 · c16 · span 1174380–1174391
266BioMarin Pharmaceutical Inc., Section 10b CEO totalDEF 14A2026-04-210001628280-26-026290CEO total compensation as printed in BioMarin Pharmaceutical Inc.'s own proxy. As printed: 21,927,563. Filing ↗machine: span 1384905–1384915
267Vertex Pharmaceuticals Incorporated, Section 10b CEO totalDEF 14A2026-04-020000875320-26-000153CEO total compensation as printed in Vertex Pharmaceuticals Incorporated's own proxy. As printed: 21,144,261. Filing ↗
268Horizon Therapeutics plc, Section 10b CEO totalDEF 14A2023-06-300001193125-23-180318CEO total compensation as printed in Horizon Therapeutics plc's own proxy. As printed: 20,103,869. Filing ↗machine: span 746414–746424
269Moderna, Inc., Section 10b CEO totalDEF 14A2026-03-160001308179-26-000081CEO total compensation as printed in Moderna, Inc.'s own proxy. As printed: 19,932,217. Filing ↗machine: span 1132888–1132898
270Jazz Pharmaceuticals plc, Section 10b CEO totalDEF 14A2026-06-080001232524-26-000029CEO total compensation as printed in Jazz Pharmaceuticals plc's own proxy. As printed: 19,151,558. Filing ↗machine: r3 · c27 · span 1437369–1437379
271United Therapeutics Corporation, Section 10b CEO totalDEF 14A2026-04-290001082554-26-000009CEO total compensation as printed in United Therapeutics Corporation's own proxy. As printed: 18,038,972. Filing ↗machine: span 1993726–1993736
272Exact Sciences Corporation, Section 10b CEO totalDEF 14A2025-04-290001124140-25-000034CEO total compensation as printed in Exact Sciences Corporation's own proxy. As printed: 15,539,378. Filing ↗machine: span 1077855–1077865
273Alnylam Pharmaceuticals, Inc., Section 10b CEO totalDEF 14A2026-04-060001628280-26-023923CEO total compensation as printed in Alnylam Pharmaceuticals, Inc.'s own proxy. As printed: 14,867,600. Filing ↗machine: span 1294691–1294701
274Neurocrine Biosciences, Inc., Section 10b CEO totalDEF 14A2026-04-150000914475-26-000015CEO total compensation as printed in Neurocrine Biosciences, Inc.'s own proxy. As printed: 13,448,935. Filing ↗machine: t50 · r4 · c7 · span 847947–847957
275Regeneron Pharmaceuticals, Inc., Section 10b CEO totalDEF 14A2026-04-240001308179-26-000340CEO total compensation as printed in Regeneron Pharmaceuticals, Inc.'s own proxy. As printed: 7,280,549. Filing ↗machine: r3 · c10 · span 3335980–3335989
276Section 10a, Exact Sciences Corporation reciprocityDEF 14A—0001124140-25-000034Exact Sciences Corporation names Seagen in its own disclosed peer group (read from its most recent proxy). Filing ↗
277Section 10a, United Therapeutics Corporation reciprocityDEF 14A—0001082554-26-000009United Therapeutics Corporation's most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗
278Section 10a, Alnylam Pharmaceuticals, Inc. reciprocityDEF 14A—0001628280-26-023923Alnylam Pharmaceuticals, Inc.'s most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗
279Section 10a, BioMarin Pharmaceutical Inc. reciprocityDEF 14A—0001628280-26-026290BioMarin Pharmaceutical Inc.'s most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗
280Section 10a, Exelixis, Inc. reciprocityDEF 14A—0000939767-26-000046Exelixis, Inc.'s most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗
281Section 10a, Horizon Therapeutics plc reciprocityDEF 14A—0001193125-23-180318Horizon Therapeutics plc names Seagen in its own disclosed peer group (read from its most recent proxy). Filing ↗
282Section 10a, Jazz Pharmaceuticals plc reciprocityDEF 14A—0001232524-26-000029Jazz Pharmaceuticals plc's most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗
283Section 10a, Moderna, Inc. reciprocityDEF 14A—0001308179-26-000081Moderna, Inc.'s most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗
284Section 10a, Neurocrine Biosciences, Inc. reciprocityDEF 14A—0000914475-26-000015Neurocrine Biosciences, Inc.'s most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗
285Section 10a, Regeneron Pharmaceuticals, Inc. reciprocityDEF 14A—0001308179-26-000340Regeneron Pharmaceuticals, Inc.'s most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗
286Section 10a, Vertex Pharmaceuticals Incorporated reciprocityDEF 14A—0000875320-26-000153Vertex Pharmaceuticals Incorporated's most recent proxy was read; its disclosed peer group does not include Seagen. Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.